Jade Biosciences (JBIO) announced the appointment of Edward Conner as chief medical officer, effective immediately. Conner joins Jade from Ardelyx (ARDX) where he served as CMO.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JBIO:
- Jade Biosciences Adopts 2026 Employment Inducement Stock Plan
- Jade Biosciences price target raised to $35 from $25 at H.C. Wainwright
- Jade Biosciences participates in a conference call with William Blair
- 3 High-Yield Dividend Stocks to Buy in Today’s Volatile Market, According to Analysts, 3/18/2026
- Jade Biosciences price target raised to $39 from $28 at BTIG